Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis
Abstract Background Atrial fibrillation is the most common arrhythmia that causes an increased risk of thromboembolism. We aimed to evaluate stroke and major bleeding risk in patients with atrial fibrillation using rivaroxaban, apixaban, dabigatran and the effects of using antiplatelet, atorvastatin...
| Published in: | BMC Neurology |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04306-1 |